-
1 Comment
Guilin Sanjin Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 3.2% below its 200 day moving average.
From a valuation standpoint, the stock is 50.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.
Guilin Sanjin Pharmaceutical Co., Ltd's total revenue sank by 32.6% to $346M since the same quarter in the previous year.
Its net income has increased by 3.7% to $64M since the same quarter in the previous year.
Finally, its free cash flow grew by 506.8% to $21M since the same quarter in the previous year.
Based on the above factors, Guilin Sanjin Pharmaceutical Co., Ltd gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| Sector | Healthcare |
| ISIN | CNE100000DY9 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Target Price | 15.92 |
|---|---|
| Market Cap | 8B |
| PE Ratio | 16.06 |
| Dividend Yield | 3.8% |
| Beta | 0.35 |
Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China and internationally. The company offers three gold particles, Guilin watermelon frost, watermelon frost lozenges, throat clearing spray, Naomaitai capsules, vertigo tablets, Xuanyunning granules, Gejie dingchuan capsule, compound panax notoginseng stomachache capsule, compound panax notoginseng stomach pain tablets, Sanqi xueshangning capsules, Sanqi xueshangning powder, compound luo han guo qing fei granules, compound luo han guo lung clearing syrup, compound red root tablets, Shuanghu zhongtongning, liver and kidney tonic granules, and jade leaf detoxification granules. Its products are used in various therapeutic areas, such as urinary system disease, oral and throat, cardiovascular and cerebrovascular disease, neurological diseases, respiratory disease, digestive system disease, internal medicine, musculoskeletal system diseases, and tonic drugs. Guilin Sanjin Pharmaceutical Co., Ltd. was founded in 1985 and is headquartered in Guilin, China. Guilin Sanjin Pharmaceutical Co., Ltd. operates as a subsidiary of Guilin SanJin Group Co.,Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002275.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
